ScinoPharm Taiwan Ltd (1789) — Cash Flow-to-Debt Ratio
ScinoPharm Taiwan Ltd (1789) has a Cash Flow-to-Debt Ratio of 0.26x as of December 2025, meaning its operating cash flow of NT$343.96 Million could theoretically repay 0% of its total liabilities (NT$1.33 Billion) in one year. See ScinoPharm Taiwan Ltd (1789) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ScinoPharm Taiwan Ltd Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for ScinoPharm Taiwan Ltd across 19 annual periods. Also explore ScinoPharm Taiwan Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ScinoPharm Taiwan Ltd (2007–2025)
Year-by-year debt coverage analysis for ScinoPharm Taiwan Ltd. For market capitalisation and broader financial context, see 1789 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | NT$597.11 Million | NT$1.33 Billion | ▼ -15.5% |
| 2024 | 0.53x | NT$750.91 Million | NT$1.42 Billion | ▲ +211.2% |
| 2023 | 0.17x | NT$231.13 Million | NT$1.36 Billion | ▼ -67.8% |
| 2022 | 0.53x | NT$773.79 Million | NT$1.46 Billion | ▲ +22.6% |
| 2021 | 0.43x | NT$509.82 Million | NT$1.18 Billion | ▼ -39.9% |
| 2020 | 0.72x | NT$946.31 Million | NT$1.32 Billion | ▲ +28.8% |
| 2019 | 0.56x | NT$788.95 Million | NT$1.41 Billion | ▼ -8.3% |
| 2018 | 0.61x | NT$1.23 Billion | NT$2.02 Billion | ▲ +43.0% |
| 2017 | 0.43x | NT$971.71 Million | NT$2.28 Billion | ▼ -34.7% |
| 2016 | 0.65x | NT$1.67 Billion | NT$2.56 Billion | ▲ +47.5% |
| 2015 | 0.44x | NT$1.04 Billion | NT$2.36 Billion | ▼ -1.0% |
| 2014 | 0.45x | NT$888.29 Million | NT$1.99 Billion | ▼ -12.6% |
| 2013 | 0.51x | NT$939.47 Million | NT$1.84 Billion | ▼ -34.0% |
| 2012 | 0.77x | NT$981.55 Million | NT$1.27 Billion | ▼ -45.0% |
| 2011 | 1.41x | NT$1.29 Billion | NT$920.78 Million | ▼ -44.2% |
| 2010 | 2.52x | NT$1.56 Billion | NT$620.97 Million | ▲ +162.4% |
| 2009 | 0.96x | NT$1.30 Billion | NT$1.35 Billion | ▲ +58.3% |
| 2008 | 0.61x | NT$1.41 Billion | NT$2.32 Billion | ▲ +273.0% |
| 2007 | 0.16x | NT$504.50 Million | NT$3.10 Billion | — |